Yuko Aoki

3.7k citations

71 papers · 3.0k · 1 hit paper · h-index 27

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Oncology top 5%
- Lung Cancer Research Studies

Papers in

Molecular Biology 40
- Cancer therapeutics and mechanisms 6
- Melanoma and MAPK Pathways 5
- Protein Kinase Regulation and GTPase Signaling 5
- PI3K/AKT/mTOR signaling in cancer 4
- Fibroblast Growth Factor Research 4
Pulmonary and Respiratory Medicine 12
- Lung Cancer Treatments and Mutations 5

Co-authors: Nobuya Ishii (19 shared papers)Nobuo Shimma (20 shared papers)Takuo Tsukuda (9 shared papers)Hiroshi Sakamoto (5 shared papers)Mikio Arisawa (9 shared papers)Takaaki A. Fukami (4 shared papers)Toshiyuki Tsukaguchi (5 shared papers)Kiyoaki Sakata (12 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Cancer Research (5 papers)Cancer Science (4 papers)Journal of Biological Chemistry (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
Partner nations: Japan United States Switzerland

In The Last Decade

Yuko Aoki

70 papers receiving 2.8k citations

Yuko Aoki's Hit Papers

align trajectories log scale

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant 2011 · 508 citations

Peers

Countries citing papers authored by Yuko Aoki

Since Specialization

Citations

This map shows the geographic impact of Yuko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Aoki more than expected).

Fields of papers citing papers by Yuko Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Aoki. The network helps show where Yuko Aoki may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuko Aoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuko Aoki Line = papers co-authored together Yuko Aoki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant Cancer Cell ·Hiroshi Sakamoto, Toshiyuki Tsukaguchi, Sayuri Hiroshima, Tatsushi Kodama, Takamitsu Kobayashi, Takaaki A. Fukami, Nobuhiro Oikawa, Takuo Tsukuda, Nobuya Ishii, Yuko Aoki Hit paper breakdown →	2011	508
2	Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells Clinical Cancer Research ·Aikou Okamoto, Takashi Nikaido, Kazunori Ochiai, Satoshi Takakura, Misato Saito, Yuko Aoki, Nobuya Ishii, Nozomu Yanaihara, Kyosuke Yamada, Osamu Takikawa, Rie Kawaguchi, Seiji Isonishi, Tadao Tanaka, Mitsuyoshi Urashima	2005	326
3	Host sphingolipid biosynthesis as a target for hepatitis C virus therapy Nature Chemical Biology ·Hiroshi Sakamoto, Koichi Okamoto, Masahiro Aoki, Hideyuki Kato, Asao Katsume, Atsunori Ohta, Takuo Tsukuda, Nobuo Shimma, Yuko Aoki, Mikio Arisawa, Michinori Kohara, Masayuki Sudoh	2005	158
4	Tetracycline-Regulatable System To Tightly Control Gene Expression in the Pathogenic Fungus Candida albicans Infection and Immunity ·Hironobu Nakayama, Toshiyuki Mio, Shigehisa Nagahashi, Michiko Kokado, Mikio Arisawa, Yuko Aoki	2000	132
5	Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity Cancer Research ·Nobuya Ishii, Naoki Harada, Eric W. Joseph, Kazuhiro Ohara, Takaaki Miura, Hiroshi Sakamoto, Yutaka Matsuda, Yasushi Tomii, Yukako Tachibana-Kondo, Hitoshi Iikura, Toshihiro Aoki, Nobuo Shimma, Mikio Arisawa, Yoshihiro Sowa, Poulikos I. Poulikakos, Neal Rosen, Yuko Aoki, Toshiyuki Sakai	2013	128
6	Crystal Structures of Candida albicans N-Myristoyltransferase with Two Distinct Inhibitors Chemistry & Biology ·Satoshi Sogabe, Miyako Masubuchi, Kiyoaki Sakata, Takaaki A. Fukami, Kenji Morikami, Yasuhiko Shiratori, Hirosato Ebiike, Ken‐ichi Kawasaki, Yuko Aoki, Nobuo Shimma, A. D’Arcy, Fritz K. Winkler, David W. Banner, Tatsuo Ohtsuka	2002	107
7	Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase Bioorganic & Medicinal Chemistry ·Miyako Masubuchi, Hirosato Ebiike, Ken‐ichi Kawasaki, Satoshi Sogabe, Kenji Morikami, Yasuhiko Shiratori, Shinji Tsujii, Toshihiko Fujii, Kiyoaki Sakata, Michiko Hayase, Hidetoshi Shindoh, Yuko Aoki, Tatsuo Ohtsuka, Nobuo Shimma	2003	106
8	Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N -myristoyltransferase. Part 1 Bioorganic & Medicinal Chemistry Letters ·Miyako Masubuchi, Ken‐ichi Kawasaki, Hirosato Ebiike, Yoshihiko Ikeda, Shinji Tsujii, Satoshi Sogabe, Toshihiko Fujii, Kiyoaki Sakata, Yasuhiko Shiratori, Yuko Aoki, Tatsuo Ohtsuka, Nobuo Shimma	2001	103
9	The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor Molecular Cancer Therapeutics ·Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, Takehito Isobe, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii	2014	101
10	N,N,N′,N′-Tetraalkyl-2,2′-dihydroxy-1,1′-binaphthyl-3,3′-dicarboxamides: Novel Chiral Auxiliaries for Asymmetric Simmons–Smith Cyclopropanation of Allylic Alcohols and for Asymmetric Diethylzinc Addition to Aldehydes Bulletin of the Chemical Society of Japan ·Hiroshi Kitajima, Katsuji Ito, Yuko Aoki, Tsutomu Katsuki	1997	96
11	Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3 Bioorganic & Medicinal Chemistry Letters ·Ken‐ichi Kawasaki, Miyako Masubuchi, Kenji Morikami, Satoshi Sogabe, Tsunehisa Aoyama, Hirosato Ebiike, Satoshi Niizuma, Michiko Hayase, Toshihiko Fujii, Kiyoaki Sakata, Hidetoshi Shindoh, Yasuhiko Shiratori, Yuko Aoki, Tatsuo Ohtsuka, Nobuo Shimma	2003	90
12	The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations Clinical Cancer Research ·Hiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura, Toshihiko Fujii, Kiyoaki Sakata, Yukako Tachibana, Jun Ohwada, Hirosato Ebiike, Shino Kuramoto, Keiichi Morita, Yasushi Yoshimura, Toshikazu Yamazaki, Nobuya Ishii, Osamu Kondoh, Yuko Aoki	2011	79
13	Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2 Bioorganic & Medicinal Chemistry Letters ·Hirosato Ebiike, Miyako Masubuchi, Pingli Liu, Ken‐ichi Kawasaki, Kenji Morikami, Satoshi Sogabe, Michiko Hayase, Toshihiko Fujii, Kiyoaki Sakata, Hidetoshi Shindoh, Yasuhiko Shiratori, Yuko Aoki, Tatsuo Ohtsuka, Nobuo Shimma	2002	66
14	Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799 Bioorganic & Medicinal Chemistry Letters ·Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada, Masao Tsukazaki, Mitsuaki Nakamura, Takuya Miyazaki, Kenji Morikami, Kiyoshi Yoshinari, Miyuki Yoshida, Osamu Kondoh, Shino Kuramoto, Kotaro Ogawa, Yuko Aoki, Nobuo Shimma	2011	56
15	Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity The Prostate ·Hiromitsu Kawata, Nobuyuki Ishikura, Miho Watanabe, Ayako Nishimoto, Toshiaki Tsunenari, Yuko Aoki	2010	56
16	Depletion of the Squalene Synthase ( ERG9 ) Gene Does Not Impair Growth of Candida glabrata in Mice Antimicrobial Agents and Chemotherapy ·Hironobu Nakayama, Miho Izuta, Noboru Nakayama, Mikio Arisawa, Yuko Aoki	2000	46
17	Asymmetric Simmons-Smith Cyclopropanation of E-Allylic Alcohols Using 1,1′-Bi-2-naphthol-3,3′-dicarboxamide as a Chiral Auxiliary Chemistry Letters ·Hiroshi Kitajima, Yuko Aoki, Katsuji Ito, Tsutomu Katsuki	1995	41
18	An orally available, small-molecule interferon inhibits viral replication Scientific Reports ·Hideyuki Konishi, Koichi Okamoto, Yusuke Ohmori, Hitoshi Yoshino, Hiroshi Ohmori, Motooki Ashihara, Yuichi Hirata, Atsunori Ohta, Hiroshi Sakamoto, Natsuko Hada, Asao Katsume, Michinori Kohara, Kazumi Morikawa, Takuo Tsukuda, Nobuo Shimma, Graham R. Foster, William Alazawi, Yuko Aoki, Mikio Arisawa, Masayuki Sudoh	2012	39
19	Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors Bioorganic & Medicinal Chemistry Letters ·Kohsuke Asoh, Masami Kohchi, Ikumi Hyoudoh, Tatsuo Ohtsuka, Miyako Masubuchi, Ken‐ichi Kawasaki, Hirosato Ebiike, Yasuhiko Shiratori, Takaaki A. Fukami, Osamu Kondoh, Toshiyuki Tsukaguchi, Nobuya Ishii, Yuko Aoki, Nobuo Shimma, Masahiro Sakaitani	2009	39
20	Azoxybacilin, a novel antifungal agent produced by Bacillus cereus NR2991. Production, isolation and structure elucidation. The Journal of Antibiotics ·Morio Fujiu, SAYOKO SAWAIRI, H Shimada, HIROKI TAKAYA, Yuko Aoki, Tôru Okuda, Kazuteru Yokose	1994	38

About Yuko Aoki

Yuko Aoki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Organic Chemistry, Oncology and Infectious Diseases, having authored 71 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (8 papers), Cancer therapeutics and mechanisms (6 papers), Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Synthesis and biological activity (5 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Biological Psychiatry (200 citations), Oncology (700 citations), Organic Chemistry (698 citations), Behavioral Neuroscience (76 citations) and Molecular Biology (1.4k citations). Yuko Aoki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Nobuya Ishii, Nobuo Shimma, Takuo Tsukuda, Hiroshi Sakamoto, Mikio Arisawa, Takaaki A. Fukami, Toshiyuki Tsukaguchi, Kiyoaki Sakata, Hirosato Ebiike and Takamitsu Kobayashi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Cancer Science, Journal of Biological Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yuko Aoki

Impact in

Papers in i

In The Last Decade

Yuko Aoki

Yuko Aoki's Hit Papers

Peers

Countries citing papers authored by Yuko Aoki

Fields of papers citing papers by Yuko Aoki

All Works

About Yuko Aoki

Explore authors with similar magnitude of impact

Papers in